Precision Immunotherapy Alliance (PRIMA) will develop the next generation of precision immunotherapy
Research Groups
PRIMA has seven research groups, each led by one of our primary investigators.
Events
– ,
Radiumhospitalet, Forskningsbygget,Seminar rooms 1/2, 1st floor
News
-
Clinical trial ahead testing safety of licensed antibody technology May 5, 2024
Antibody candidate developed with new technology from Jan Terje Andersen's group is now in clinical trial to test the safety in healthy participants
-
Publication in Nature Reviews from the Malmberg group Apr. 24, 2024
"Engineering immune-evasive allogeneic cellular immunotherapies"